BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28694144)

  • 1. AT2 receptors in cardiovascular and renal diseases.
    Kaschina E; Namsolleck P; Unger T
    Pharmacol Res; 2017 Nov; 125(Pt A):39-47. PubMed ID: 28694144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
    Chow BS; Allen TJ
    Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT2 receptors: functional relevance in cardiovascular disease.
    Jones ES; Vinh A; McCarthy CA; Gaspari TA; Widdop RE
    Pharmacol Ther; 2008 Dec; 120(3):292-316. PubMed ID: 18804122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT2 receptor activities and pathophysiological implications.
    Matavelli LC; Siragy HM
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):226-32. PubMed ID: 25636068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT(2) receptor and tissue injury: therapeutic implications.
    Namsolleck P; Recarti C; Foulquier S; Steckelings UM; Unger T
    Curr Hypertens Rep; 2014 Feb; 16(2):416. PubMed ID: 24414230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.
    Paulis L; Foulquier S; Namsolleck P; Recarti C; Steckelings UM; Unger T
    Drugs; 2016 Jan; 76(1):1-12. PubMed ID: 26631237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
    Nguyen L; Ager EI; Neo J; Christophi C
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1773-1782. PubMed ID: 26849969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AT
    Colin M; Delaitre C; Foulquier S; Dupuis F
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of AT1 and AT2 receptors in the nucleus of the solitary tract in cardiovascular responses induced by a high-fat diet.
    Speretta GF; Ruchaya PJ; Delbin MA; Melo MR; Li H; Menani JV; Sumners C; Colombari E; Bassi M; Colombari DSA
    Hypertens Res; 2019 Apr; 42(4):439-449. PubMed ID: 30631157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 2 receptor in hypertensive cardiovascular disease.
    Savoia C; D'Agostino M; Lauri F; Volpe M
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):125-32. PubMed ID: 21245762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.
    Skorska A; von Haehling S; Ludwig M; Lux CA; Gaebel R; Kleiner G; Klopsch C; Dong J; Curato C; Altarche-Xifró W; Slavic S; Unger T; Steinhoff G; Li J; David R
    J Cell Mol Med; 2015 Aug; 19(8):1975-85. PubMed ID: 25991381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.
    Rai P; Lederman R; Haque S; Rehman S; Kumar V; Sataranatrajan K; Malhotra A; Kasinath BS; Singhal PC
    Exp Mol Pathol; 2014 Jun; 96(3):431-7. PubMed ID: 24768585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.
    Verma A; Zhu P; de Kloet A; Krause E; Sumners C; Li Q
    Exp Eye Res; 2019 Oct; 187():107770. PubMed ID: 31449794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Angiotensin AT
    Steckelings UM; Widdop RE; Sturrock ED; Lubbe L; Hussain T; Kaschina E; Unger T; Hallberg A; Carey RM; Sumners C
    Pharmacol Rev; 2022 Oct; 74(4):1051-1135. PubMed ID: 36180112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Other Angiotensin II Receptor: AT
    Juillerat-Jeanneret L
    J Med Chem; 2020 Mar; 63(5):1978-1995. PubMed ID: 32030982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor blockers: Focus on cardiac and renal injury.
    Arumugam S; Sreedhar R; Thandavarayan RA; Karuppagounder V; Krishnamurthy P; Suzuki K; Nakamura M; Watanabe K
    Trends Cardiovasc Med; 2016 Apr; 26(3):221-8. PubMed ID: 26169314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT
    Kaschina E; Lauer D; Lange C; Unger T
    Biochem Pharmacol; 2024 Apr; 222():116062. PubMed ID: 38369211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT
    Assersen KB; Sumners C; Steckelings UM
    Can J Cardiol; 2020 May; 36(5):683-693. PubMed ID: 32389341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.